These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6687937

  • 1. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G.
    Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
    [Abstract] [Full Text] [Related]

  • 2. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW.
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
    Walti H, Relier JP, Huon C, Monset-Couchard M, Scemama M, De Gamarra E, Moriette G, Curstedt T, Robertson B.
    Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
    [Abstract] [Full Text] [Related]

  • 4. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

  • 5. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A.
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [Abstract] [Full Text] [Related]

  • 6. The late administration of surfactant.
    Ballot DE, Rothberg AD, Davies VA.
    S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080
    [Abstract] [Full Text] [Related]

  • 7. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
    Namgung R, Lee C, Suh JS, Park KI, Han DG.
    Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
    [Abstract] [Full Text] [Related]

  • 8. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S, Raju TN, Bhat R, Maeta H, Vidyasagar D.
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [Abstract] [Full Text] [Related]

  • 9. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U, Promwong N, Kanjanapattanakul W, Khorana M, Sangtawesin V, Horpaopan S.
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [Abstract] [Full Text] [Related]

  • 10. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O, Lapillonne A, Madinier-Chappat N, Miguet D, Salle BL.
    Cah Anesthesiol; 1994 Oct; 42(3):325-8. PubMed ID: 7812856
    [Abstract] [Full Text] [Related]

  • 11. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O, Kale G.
    Pathol Res Pract; 2009 Oct; 205(1):35-41. PubMed ID: 18951732
    [Abstract] [Full Text] [Related]

  • 12. Early and late surfactant treatments in baboon model of hyaline membrane disease.
    Maeta H, Vidyasagar D, Raju TN, Bhat R, Matsuda H.
    Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477
    [Abstract] [Full Text] [Related]

  • 13. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
    Gonda TA, Hutchins GM.
    Am J Perinatol; 1998 Feb; 15(9):539-44. PubMed ID: 9890252
    [Abstract] [Full Text] [Related]

  • 14. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease.
    Raju TN, Vidyasagar D, Bhat R, Sobel D, McCulloch KM, Anderson M, Maeta H, Levy PS, Furner S.
    Lancet; 1987 Mar 21; 1(8534):651-6. PubMed ID: 2882083
    [Abstract] [Full Text] [Related]

  • 15. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
    Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ.
    J Pediatr; 1990 Jan 21; 116(1):119-24. PubMed ID: 2404097
    [Abstract] [Full Text] [Related]

  • 16. Hyaline membrane disease: recent developments.
    Eur J Obstet Gynecol Reprod Biol; 1983 Aug 21; 15(4-6):409-24. PubMed ID: 6352356
    [No Abstract] [Full Text] [Related]

  • 17. Surfactant improves gas mixing and alveolar ventilation in preterm lambs.
    Sandberg K, Edberg KE, Benton W, Silberberg A, Sladek M, Sundell HW.
    Pediatr Res; 1991 Aug 21; 30(2):181-9. PubMed ID: 1896264
    [Abstract] [Full Text] [Related]

  • 18. Mechanical ventilation in newborn infants with hyaline membrane disease;
    Jones MD, Murton LJ.
    Pediatr Ann; 1977 Apr 21; 6(4):253-61. PubMed ID: 323798
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study].
    Sánchez-Mendiola M, Martínez-Natera OC, Herrera-Maldonado N, Ortega-Arroyo J.
    Gac Med Mex; 2005 Apr 21; 141(4):267-71. PubMed ID: 16164120
    [Abstract] [Full Text] [Related]

  • 20. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome].
    Morón A, Luaces J, Esteban JC, Medina D, Sánchez JM, Manzano JL.
    Med Clin (Barc); 1996 Jun 29; 107(5):165-8. PubMed ID: 8758674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.